Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPARC1310 in Seasonal Allergic Rhinitis
NCT01940146Phase 2Completed
- Sponsor
- Sun Pharma
- Start
- Oct 2014
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of SPARC1310 in seasonal allergic rhinitis (SAR), sponsored by Sun Pharma. Started Oct 2014; status: completed.
02
Drugs
SPARC1310
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT01940146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01940146.